Semi-solid tumor model in Xenopus laevis/gilli cloned tadpoles for intravital study of neovascularization, immune cells and melanophore infiltration  by Haynes-Gimore, Nikesha et al.
Semi-solid tumor model in Xenopus laevis/gilli cloned tadpoles
for intravital study of neovascularization, immune cells
and melanophore inﬁltration
Nikesha Haynes-Gimore a,b, Maureen Banach a, Edward Brown c, Ryan Dawes c,
Eva-Stina Edholm a, Minsoo Kim a,d, Jacques Robert a,n
a Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA
b Department of Pathology, University of Rochester Medical Center, Rochester, USA
c Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, USA
d Center for Vaccine Biology and Immunology, Rochester, USA
a r t i c l e i n f o
Article history:
Received 3 September 2014
Received in revised form
29 October 2014
Accepted 8 January 2015
Available online 17 January 2015
Keywords:
Tumor model
Angiogenesis
Tumor immunity
Intravital microscopy
Tumor microenvironment
a b s t r a c t
Tumors have the ability to grow as a self-sustaining entity within the body. This autonomy is in part
accomplished by the tumor cells ability to induce the formation of new blood vessels (angiogenesis) and
by controlling cell trafﬁcking inside the tumor mass. These abilities greatly reduce the efﬁcacy of many
cancer therapies and pose challenges for the development of more effective cancer treatments. Hence,
there is a need for animal models suitable for direct microscopy observation of blood vessel formation
and cell trafﬁcking, especially during early stages of tumor establishment. Here, we have developed a
reliable and cost effective tumor model system in tadpoles of the amphibian Xenopus laevis. Tadpoles are
ideally suited for direct microscopy observation because of their small size and transparency. Using the
thymic lymphoid tumor line 15/0 derived from, and transplantable into, the X. laevis/gilli isogenic clone
LG-15, we have adapted a system that consists in transplanting 15/0 tumor cells embedded into rat
collagen under the dorsal skin of LG-15 tadpole recipients. This system recapitulates many facets of
mammalian tumorigenesis and permits real time visualization of the active formation of the tumor
microenvironment induced by 15/0 tumor cells including neovascularization, collagen rearrangements
as well as inﬁltration of immune cells and melanophores.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Tumors have the remarkable ability to control the host micro-
environment and promote blood vessel formation (angiogenesis) for
enhancing their own growth, expansion and metastasis. Until
recently, the formation of blood vessels was considered to be a
process limited to embryogenesis. However, the formation of new
blood vessels at later life stages is critical for tissue regeneration and
wound healing processes [reviewed in (Tonnesen et al., 2000)].
Furthermore, angiogenesis is critical for tumorigenesis and metas-
tasis as growing tumors require increasing amounts of oxygen and
nutrients (Hanahan and Folkman, 1996). Once a growing tumor
lesion exceeds a few millimeters, it initiates the development of new
blood vessels from pre-existing host capillaries that are stimulated
by pro-angiogenic signals expressed by tumor cells (Onimaru and
Yonemitsu, 2011). Unlike normal tissues, the vasculature within the
tumor mass is typically disorganized, leaky and the walls of tumor
vessels are composed of both endothelial cells and tumor cells,
which transform into “endothelial-like cells” (Chang et al., 2000;
Maniotis et al., 1999). As such, there is a great fundamental and
biomedical interest in understanding the dynamics of blood vessel
formation during tumorigenesis, especially at the early stage of
tumor establishment. To study this process in vivo, real time
observation by intravital microscopy has gained much attention.
To date this approach has been mainly developed in mouse and
zebraﬁsh models (Li et al., 2012; Nguyen et al., 2012; Painter and
Ceol, 2014). However, the Xenopus laevis tadpoles could provide a
useful alternative.
Xenopus has been and still is one of the top model systems for
the study of fundamental questions related to development,
immunology, toxicology, neurobiology, embryology and regenera-
tive biology (Du Pasquier et al., 1989; Khokha, 2012; Robert and
Ohta, 2009). More recently Xenopus has also been increasingly
used as a model for understanding tumor biology, transplantation
biology, self tolerance and autoimmunity [reviewed in (Edholm
and Robert, 2013). Xenopus possesses many attributes that make it
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an ideal model to study fundamental questions about tumor
immunity and tumorigenesis including an external development,
without maternal inﬂuences, thus providing convenient experi-
mental manipulation at all stages of development. Elements that
make the Xenopus tadpoles in particular attractive for experimen-
tation are their transparency, small size (10–20 mm length) and as
ectothermic vertebrates they tolerate room temperature and do
not require highly aseptic conditions for observation, thus making
them ideally suited for techniques such as intravital microscopy.
Additionally, MHC-deﬁned X. laevis/X. gilli (LG) isogenetic clones
permit adoptive cell transfers (Kobel and Du Pasquier, 1975, 1977).
Importantly, X. laevis is the only known amphibian species with
spontaneously arising and transplantable lymphoid tumors (Goyos
and Robert, 2009). The 15/0 tumor cell line was derived from a
spontaneous thymic tumor in the LG-15 clone (Robert et al., 1994).
The X. laevis 15/0 tumor is highly tumorigenic and grows aggres-
sively in both LG-15 and LG-6 adults and tadpoles, which share the
same MHC haplotypes (a/c) but differ at multiple minor H loci. As
in mammals, the 15/0 tumors can only be transplanted and grow
in MHC compatible LG-6 and LG-15 cloned recipients, whereas
they are rejected when transplanted into MHC mismatched strains
and clones as well as into outbred animals. The 15/0 tumor can be
easily distinguished from other cells by the surface expression of
the immature thymocyte marker CTX (Du Pasquier and Robert,
1992; Robert and Cohen, 1998; Robert et al., 1994).
We have recently adapted for Xenopus a semi-solid tumor
transplantation model to investigate the role of a nonclassical
MHC molecule in tumor immune evasion (Haynes-Gilmore et al.,
2014). Tumor cells are transplanted into the LG-15 adult frogs
subcutaneously, after which animals are monitored for date of ﬁrst
tumor appearance and tumor volume. The 15/0 tumors can then
be palpated within 2 weeks of transplantation in healthy immu-
nocompetent animals and within one month large solid tumors
with metastatic outgrowths are typically observed in the spleen,
liver and kidney (Robert et al., 1994). Conversely, 15/0 tumor cells
are intraperitoneally transplanted into LG-15 tadpoles where it
grows as an ascites within the peritoneum of larval recipients with
frequent metastatic sites observed (Robert et al., 1994). Because of
the difﬁculty of tracing tumor cells injected in suspension in the
peritoneum, it is unclear as to what happens during the early
stages of tumor establishment in Xenopus tadpole. In particular,
the interactions of tumor cells with host immune effectors, the
stroma and blood circulation at different stages of tumor devel-
opment are still poorly characterized. A better understanding of
the modalities of these interactions would be achieved by con-
trolling the tumor's location as well as the direct visualization of
the tumor fate. Thus, using the 15/0 tumor in the LG-15 and LG-6
tadpole system we developed a semi-solid tumor assay.
We demonstrate here a method for the intravital study of
neoangiogenesis and tumor-immune interactions in the X. laevis
tadpole, which may be subsequently used for the investigation of
tumor microenvironmental interactions, as well as facilitate the
discovery and development of new cancer immunotherapeutic
and anti-angiogenic therapies.
Materials and methods
Animals
LG-6 and LG-15 Xenopus cloned tadpoles were obtained from
our breeding colony (http://www.urmc.rochester.edu/smd/mbi/
xenopus/index.htm). These two clones are MHC identical (a/c)
but differ at multiple minor histocompatibility loci. Transplanted
15/0 tumor cells grow similarly into both LG clones (Robert et al.,
1994). All experiments were done with either stage 54–55 (two
week old; (Nieuwkoop and Faber, 1967)) tadpoles or young (one
year old) adults. Animals were anesthetized by immersion in
tricaine methanesulfonate (TMS; 0.1 g/L). All animals were
handled under strict laboratory and UCAR regulations (Approval
number 100577/2003-151) minimizing discomfort at all times.
Preparation of tumor embedded collagen grafts
Setting solution (10 EBSSþ0.2 M NAHCO3þ0.15 M NaOH)
was added drop-wise to rat-tail collagen (BD Biosciences) on ice
until the pH of the collagen was neutralized as previously
described. The 15/0 tumor cells were then mixed with the collagen
solution at a concentration of 500,000 cells per 10 μL graft.
Collagen/tumor mix was then pipetted into individual wells of
6 well plates and incubated at 27 1C for 30 min to allow collagen
polymerization. Two milliliters of 15/0 media, previously
described (Lu et al., 2012) was added to 15/0 collagen grafts.
Plates containing the grafts were then incubated at 27 1C in
chambers containing a blood gas mix (5% CO2, 21% O2, 74% N)
until use.
Tumor grafts
Small subcutaneous incisions were made on anterior left or
right region of tadpoles and the collagen tumor grafts were
inserted subcutaneously within the incision. Digital images were
taken using an SMZ1500 Nikon stereomicroscope equipped with a
DS-Qil monochrome cooled digital camera (Nikon) and areas of
tumor grafts were determined using ImageJ software (NIH).
Histology
Seven days post grafting, collagen embedded tumor grafts were
removed and processed for cryosection. Serial 8 μM sections were
taken and 5th section was stained with haematoxylin and eosin
(H&E) or Gömöri trichrome to distinguish collagen. Tumor col-
lagen grafts were allowed to grow for three weeks when ascites
ﬂuid was removed and placed onto slide by cytospin then stained
with Giemsa as previously described (Morales et al., 2010). Slides
were examined using an Axiovert 200 inverted microscope and
Inﬁnity 2 digital camera (objective: 40/0.6, Zeiss).
Imaging of semi-solid tumor vasculature
Ex vivo conventional ﬂuorescence imaging
Anesthetized LG-15 tadpoles were injected intracardiacally
with 10 μL of 70,000 MW (25 mg/mL) Texas-red dextran (Invitro-
gen) to label the blood vessels. Approximately 10 min later 15/0-
collagen tumor grafts were mounted onto slides and blood vessels
and tumor cells were visualized using the Olympus BX40 conven-
tional ﬂuorescence microscope (Olympus America Inc.), and
images acquired using the Retga 1300 camera (QImaging). Two-
color images (Texas-red-dextran/PKH) were combined and ana-
lyzed using Image J software (NIH). For Confocal Intravital ima-
ging: LG-6 tadpoles were anesthetized by immersion in TMS. They
were then intracardiacally injected with 10 μL of 70,000 MW
(25 mg/mL) Texas-red dextran (Invitrogen) to label the blood
vessels approximately 10 min before imaging. Animals were
stabilized for imaging in between a solidiﬁed 1% agarose matrix
made inside an imaging plate. Image acquisition was conducted on
an epiﬂuoresence microscope (TE2000-U microscope; Nikon)
using 4–20 objectives coupled to a Cool SNAP HQ CCD (Roger
Scientiﬁc).
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Multiphoton intravital imaging
Approximately 10 min prior to imaging, anesthetized tadpoles
were injected intracardiacally with 10 mL of 2106 MW (2.5 mg/mL)
tetramethyl rhodamine-conjugated dextran (Invitrogen) to label
blood vessels. Intravital ﬂuorescence and collagen second harmonic
generation (SHG) microscopy were simultaneously performed using
a custom multiphoton laser scanning microscope featuring a mod-
iﬁed Fluoview FV300 confocal scan head (Olympus Optical) con-
nected to a BX61WI upright microscope (Chen et al., 2012;
Majewska et al., 2000). Excitation light was provided by a Mai Tai
Ti:Sapphire laser (Spectra-Physics), delivering 810 nm light in 100
femptosecond pulses at 80 MHz. Prior to entering the scan box, laser
light was circularly polarized by a Berek compensator (Model 5540,
New Focus), thereby preventing the selective imaging of parallel-
oriented collagen ﬁbers (Campagnola, Nature Protocols 2012). An
Olympus UMPLFL20XW water immersion objective (20 , 0.95 NA)
was used to focus excitation light and collect emitted/scattered light.
Emitted/scattered light (immunoﬂuorescence and SHG, respectively)
were separated from the excitation light by a 670 nm short-pass
dichroic mirror. Tetramethyl rhodamine-conjugated dextran ﬂuor-
escence was collected using a 605/55 nm bandpass ﬁlter (Chroma),
while CFSE ﬂuorescence was collected using a 535/40 nm bandpass
ﬁlter (Chroma). Collagen SHG images were collected using a 405/
30 nm bandpass ﬁlter (Semrock). Simultaneous tetramethyl-rhoda-
mine/SHG and CFSE/SHG imaging were performed using a 565 nm
dichroic mirror (Chroma). Fluorescence emission and SHG scattering
were detected using non-descanned photomultiplier tubes (HC125-
02; Hamamatsu) in whole ﬁeld detection mode. Images were
acquired using Olympus Fluoview software at 10241024 pixels
using Kalman averaging. Z stacks were constructed using a 10 mM
step size beginning at top most area of the graft just below the skin
(to avoid cutaneous melanophores) and extending to the bottom of
the graft (demarked by the loss of detectable collagen SHG). Three-
color images (TMR-dextran/CFSE/SHG) were combined and analyzed
using ImageJ software (NIH).
Statistical analysis
All quantitative data were analyzed using either students TTEST
or a one-way ANOVA using the Vassar Stat software (www.
vassarstats.net).
Results
Growth of the 15/0 tumor within semi-solid tumor grafts
The thymic lymphoid 15/0 tumor grows robustly in vivo when
transplanted intraperitoneally into genetically compatible LG-15
or LG-6 cloned tadpoles (Robert et al., 1994). However, this type of
transplantation is not suitable for direct observation of tumor
architecture and tumor-induced neovascularization. Owing to the
transparency of the tadpoles' skin we reasoned that the immobi-
lization of tumor cells on a solid matrix would permit such
visualization. Thus, we embedded 15/0 tumor cells into rat-tail
type I collagen. Once polymerized, the tumor was engrafted
subcutaneously on the anterior left and right regions of two-
week old LG-15 or LG-6 tadpoles (Fig. S1).
For the initial assessment of this tumor assay, we delineated
the in vivo growth potential of the 15/0 containing collagen (15/0-
collagen) semi-solid grafts within syngeneic LG-15 tadpoles.
Animals were subcutaneously grafted with either collagen alone
or 15/0-collagen, and then tumor growth was monitored over time
(Fig. 1A). The 15/0-collagen grafts showed steady growth over a
one-month period, whereas collagen alone grafts showed little to
no changes of the relative area compared to day 0 indicating that
tadpoles tolerated the rat collagen (Fig. 1B). We next determined
whether the 15/0 tumor cells could be visualized within the 15/0-
collagen grafts. Accordingly, we performed intra-vital multiphoton
imaging on LG-6 tadpoles grafted with CFSE-labeled 15/0 tumor
collagen embedded grafts. After one week of in vivo growth,
numerous CFSE ﬂuorescent 15/0 tumor cells were detected within
the collagen matrix (Figs. S2 and 3C), indicating that the 15/0
tumor cells within the collagen grafts were proliferating.
Visualization of tumor cells within the collagen matrix of the semi-
solid graft
We next determined the ability of rat collagen to allow Xenopus
15/0 tumor cell growth in vitro and in vivo. 15/0 tumor cells were
embedded into collagen and maintained either in in vitro culture
for 9 days (tissue culture conditions described in the methods) or
subcutaneously grafted into LG-15 tadpoles for 9 days after which
the grafts where removed and cells were visualized using the
nuclear DAPI counter staining. Both in in vitro (Fig. 2A, I and IV)
and in vivo (Fig. 2A; II and V) conditions, 15/0 cells accumulated
throughout the graft and no marked apoptosis (e.g., picnotic
Fig. 1. In vivo growth of 15/0 semi-solid tumor grafts. (A) Representative images of
collagen alone (I) and 15/0 tumor grafts (dashed white line) at day 3, 10, 16, 24 and
30 following engraftment (II–VI). Note the accumulation of melanophores in the
tumor grafts at later time points. (B) Average increase in area 7SEM of tumor or
collagen only grafts determined over time relative to collagen only graft at day 0.
Values are expressed as the mean7SEM from 15 animals in 3 independent
experiments. P values calculated using students TTEST. LG-15, stage 54 (2 week
old) tadpoles were subcutaneously grafted with 500,000 cells of 15/0 tumor while
control animals were grafted with equal volume of collagen alone. Animals were
imaged on a Nikon SMZ1500 stereomicroscope.
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nuclei) was noted. Combined, these results show that the embed-
ding of the 15/0 tumor cells within the collagen does not hinder
the proliferation and viability of the tumor cells.
To further characterize the in vivo growth of the collagen-
embedded 15/0 tumor grafts, we performed histological analysis
on cryosection of tumor-bearing animals at varying times post-
implantation. H&E staining of cryosections containing tumor graft
as well as the eye and portion of the brain were obtained. Interest-
ingly, as the tumor progressed and increased in volume, there were
considerable morphological and positional changes of the tumor cells
within the collagen matrix. During the ﬁrst few days after tumor
engraftment, tumor cells were irregularly interspaced throughout
the graft with no discernible patterns (Fig. 2B, I and V). Tumor
cells exhibited a rounded morphology. As tumorigenesis progressed,
Fig. 2. Characterization of 15/0 tumor cells within the semi-solid tumor graft. (A) Semi-solid tumors containing 500,000 15/0 tumor cells were either grown for 9 days
in vitro (I and IV) or grafted subcutaneously in vivo in LG-15 tadpoles (II and V). Control collagen mass without tumor cells was maintained in vitro (III and VI). Semi-solid
tumors were then stained with 0.1 μg/ml DAPI (II, IV, and VI) and cells visualized using a Leica DMIRB inverted ﬂuorescence microscope. (B) H&E staining of cryosections of
tumor collagen grafts 3, 10, 16 and 30 days post-transplantation (I–IV). Magniﬁed images of boxed section from above panel (V–VIII). Slides were imaged using an Axiovert
200 inverted microscope. (C) Gömöri trichrome staining of cryosections of tumor collagen grafts 3, 10, 16 and 30 days post-transplantation (I–IV) Magniﬁed images of boxed
section from above panel (V–VIII). Slides were visualized using an Axiovert 200 inverted microscope.
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signiﬁcant tumor morphogenesis was observed (Fig. 2B, II–II and VI–
VII) with “granuloma like” structures observed at day 30 (Fig. 2B, IV
and VIII). The tumor cells took on a stretched out, stromal morphol-
ogy, forming swirl like structures.
To reveal possible modiﬁcation of the collagen matrix during
tumor progression we stained the tissues with Gömöri trichrome,
which distinguishes plasma from connective tissue including col-
lagen. At early time points following tumor engraftment (Day 3),
15/0-collagen grafts exhibited diffuse spatial pattering of collagen,
with pockets of tumor cells throughout the graft including some
areas of collagen void of tumor cells (Fig. 2C, I and V). At intermediate
time points (days 10–16) post-tumor engraftment, more organized
collagen ﬁbrils were detected within the graft and tumor cells were
more uniformly dispersed throughout the tumor mass, typically
lining up along the collagen ﬁbers (Fig. 2B II–III, VI–VII). In the more
advanced stage of tumor growth (30 days post-engraftment), tumor
cells along with invading melanophores and immune cells were
organized in a stratiﬁed layer pattern surrounding the remaining
collagen forming “granuloma-like” structures (Fig. 2B IV and VII).
Collectively, these data show not only that the 15/0 tumor cells
are able to effectively grow within rat collagen embedded grafts
but also that these tumor cells undergo morphogenetic changes
resulting in the reorganization of the tumor microenvironment.
Visualization of neo-angiogenesis within the semi solid tumor graft
Solid tumors usually require additional nutrients to support
growth once its dimensions surpass a few millimeters. Given the
steady growth of 15/0 tumor within the grafted collagen mass, we
reasoned that initiation of neovasculature should occur to support
continuous growth. To assess the formation of new vasculature
inside 15/0 tumor-collagen grafts, we grafted collagen embedded
with 15/0 tumor cells labeled with the plasma membrane ﬂuorescent
dye PKH-26. At different time points post-grafting, anesthetized
animals were intracardiacally infused with Texas-red labeled dextran
and given time (10 min) to allow for complete circulation of the dye
throughout the tadpole vasculature before removing the grafts for
imaging. Texas-red dextran ﬁlled vasculature was observed in 15/0-
collagen grafts within seven days following engraftment (Figs. 3A
and S4). These vessels displayed varying sizes (2–10 μm diameter),
shapes and branching patterns within the collagen tumor.
To further visualize the tumor neovasculature, we performed
intra-vital imaging of Texas-red loaded vessels within 15/0-col-
lagen grafts in tadpole recipients 2 weeks post-implantation.
Bright ﬁeld observation showed blood ﬂow within the tumor
and surrounding tissue (Fig. 3B; I). Although no speciﬁc measure-
ment was performed, we observed that the rate of blood ﬂow
appeared to decrease upon entering the semi-solid tumor. In
addition, some of the vasculature seemed to be either occluded
and have turbulent blood ﬂow, whereas other tumor vessels had
slow laminar blood ﬂow. To further conﬁrm the presence of
vasculature within the tumor and whether the normal vasculature
branched into the tumor vasculature, we examined the Texas-red
ﬂuorescence in and around the tumor. As depicted in Fig. 3B,
Texas-red ﬂuorescence revealed larger vessels entering the tumor
that branched into multiple smaller vessels gradually progressing
deeper into the tumor (Fig. 3B). Imaging further into the tumor
revealed a convoluted network of blood vessels (Fig. 3C).
To further elucidate the complexity of the tumor microenviron-
ment, we adapted a two photon imaging system such that we could
simultaneously monitor tumor cells, tumor vasculature and immune
effector cells within the collagen matrix. Taking advantage of the
inherent physical and structural properties of type I collagen, we
imaged the collagen matrix using multiphoton SHG microscopy. We
initially tested whether we could detect vasculature and collagen
intravitally in our tadpole model system. Indeed, Texas-red ﬁlled
normal vasculature (Fig. S3A) and SHG in non-tumor cells bearing
collagen grafts (Fig. S3B) could be visualized within LG-15 tadpoles.
We then proceeded to observe tumor angiogenesis within LG-15 and
LG-6 tadpole recipients grafted with 15/0-embedded collagens. Initial
intravital imaging sessions demonstrated that the 70,000 MW TRITC
dextran used in the above experiments rapidly leaked from vessels
nearby tumors, thus necessitating the use of a higher molecular
weight ﬂuorescent dextran (tetra methyl rhodamine 2106 MW
(TMR) dextran) to ensure conﬁned labeling of tumor-associated
vessels. Collagen grafts containing CFSE-labeled 15/0 tumor cells were
implanted into both LG-15 and LG-6 tadpoles and intravital multi-
photon imaging was performed at varying time points between 1 and
2 weeks. We observed TMR dextran ﬁlled vasculature in the tumor
graft in both LG-15 and LG-6 hosts as evidenced by overlapping TMR
staining with CFSE ﬂuorescence cells and SHG collagen signal (Fig. 3C).
It is noteworthy that the SHG signal became undetectable in advanced
15/0-collagen grafts after approximately two weeks post-transplanta-
tion, but not in grafts of collagen alone at similar time points (data not
shown), suggesting that the growing 15/0 tumor cells readily modiﬁed
the transplanted collagen matrix.
Induced migration of melanophores into 15/0 semi-solid tumor grafts
During tumor engraftment experiments we noticed that 15/0
tumor-embedded collagen (Fig. 4A) but not collagen only grafts
(Fig. 1A) became heavily inﬁltrated with melanophores. In mam-
mals, melanocytes are usually located within the basement mem-
brane of the epidermis. The genetic alteration of essential
signaling pathways within melanocytes often leads to malignant
transformation, thus promoting the abnormal migration and
accumulation of melanocytes resulting in melanoma [reviewed
in (Uong and Zon, 2010)]. Therefore, the unusual tadpole melano-
phores inﬁltration into 15/0 tumor grafts warranted further
examination. Increased inﬁltration of melanophores was observed
in virtually all 15/0 tumor grafts from one week post-
transplantation onward. Accumulation of these cells became more
pronounced a later time points and at 3 weeks post-
transplantation about 60% of the 15/0 graft were massively
invaded and black in color as depicted in Figs. 1A and 4A). Within
these larger more advanced tumor grafts, melanophores accumu-
lated not only at the surface of the graft but also invaded deeply
inside of the tumor mass (Fig. 4B). Ex vivo bright ﬁeld imaging of
these 15/0-collagen grafts showed that melanophores migrated
into the whole tumor graft spreading their dendrites throughout
the collagen matrix and tumor cells (Fig. 4C). Penetration of
melanophores inside the tumor mass is also evident in tissue
sections of Fig. 2B (especially panel VIII) and Fig. 3B. To further
characterize these melanophores and determine their proliferation
capacity we cultured them in vitro. To obtain enriched melano-
phores cultures we took advantage of the fact that 15/0 tumor cells
are unable to survive when cultured in amphibian culture medium
without normal Xenopus serum supplementation (Robert et al.,
1994). This allowed us to obtain cell culture constituted mainly of
melanophores and ﬁbroblast surviving more than 4 weeks, albeit
not proliferating in vitro (Fig. 4D). Nevertheless the possibility to
obtain relatively number large numbers (1–2106 cells per
tadpoles) of melanophores in culture should be of interest for
further investigation. In addition, since these cells are derived
from LG-15 or LG-6 isogenic clones, adoptive cells transfer will be
possible to determine their migration capability.
Discussion
The semi-solid tumor engraftment system we have adapted in
Xenopus tadpoles provides an attractive comparative system for
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gathering new insights into the development and establishment of
the tumor microenvironment. The 15/0 thymic lymphoid tumor
and the Xenopus host immune response are relatively well
characterized (reviewed in (Goyos and Robert, 2009)). Here, we
have established the initial conditions to visualize in real time the
active formation of the tumor microenvironment induced by 15/0
tumor cells including neovascularization, collagen rearrangements
as well as inﬁltration of melanophores.
How tumor cells modify their surrounding microenvironment i.e.
immune mediators, stromal cells, extracellular matrix proteins as
well as neo-angiogenesis is an active area of research owing to the
fact that these interactions are crucial for promoting tumor
growth and invasiveness (Weis and Cheresh, 2011). Tumor
angiogenesis is essential to support and promote growth and
metastasis. Thus, understanding blood vessel formation during
tumorigenesis may provide new ways in which tumor vasculature
can be manipulated for the treatment of cancer. For the ﬁrst time in
a frog model we have shown rapid robust tumor vessel neo-
formation, which recapitulates many properties already described
in human tumor angiogenesis. The neovascularization occurring in
the 15/0 tumor engraftment in the Xenopus tadpole presents many
similarities with mammalian tumor angiogenesis. In particular,
similar to mammals, 15/0 tumor-induced angiogenesis results in
the formation of a disorganized blood vessel network with intricate
branching and anastomosis (Yang et al., 2001). The blood ﬂow
within 15/0 tumor vessels also appeared to be slower than in other
adjacent healthy tissues as it is observed in mammalian tumors.
Notably, the vascular disorganization is thought to be one of the
reasons that intravenous chemotherapies are not fully effective. This
is due to the difﬁculty of efﬁciently perfusing the tumor with
chemotherapeutic agents as a result of the disorganized properties
of the tumor vasculature (Kerbel, 2000). The transparency of the
tadpole skin and its tolerance to room temperature are convenient
attributes for intravital observation of early stages of neovascular-
ization that start within a few days after engraftment.
Also reminiscent of mammalian tumor establishment is the
reorganization and degradation of the extracellular matrix here
constituted mainly of type I rat collagen (Fig. 2). Collagen is one of
numerous components of the cellular microenvironment. How
tumor cells are able to modify the collagen and whether this
modiﬁcation leads to any metastatic out growth is an active area of
research. Interestingly, it is known that in many cancers the
modiﬁcation of the extracellular matrix is necessary for metastatic
outgrowth [reviewed in (Lu et al., 2012)]. For example, type I
collagen produced by stromal ﬁbroblast in the tumor microenvir-
onment can promote tumor growth in breast cancer (Kim et al.,
2014). In addition, tumor cells are known to secrete enzymes such
as metalloproteases to degrade extracellular matrix including
collagen to facilitate invasion (Zhang et al., 2014). Thus, using
our model we can now study how collagen modiﬁcation can
modulate tumor growth.
For effective and sustained growth, tumor cells have to elude
host defense mechanisms ideally suited to effectively recognize
and destroy cells undergoing neoplastic transformations (Gajewski
et al., 2011). Notably, tumors promote potent suppressive environ-
ment by recruiting a variety of suppressive leukocytes such as
macrophages (Marigo et al., 2008; Shevach, 2009; Sica et al.,
2008). Our study shows that we can effectively visualize tumor
Fig. 3. Neo-angiogenesis in 15/0 collagen grafts. LG-6 or LG-15 tadpoles were grafted with tumor grafts containing 500,000 15/0 tumor cells and animals were
intracardiacally injected with either Texas red 70 KDa or TMR 2000 KDa dextran and imaged. (A) Ex vivo images of vascularized grafts from LG-15 tadpoles at day 7 post-
transplantation. PKH-labeled 15/0 cells (I) with Texas red-dextran ﬁlled vasculature (II). Vascularized tumors were imaged ex vivo using an Olympus BX40 conventional
ﬂuorescence microscope. (B) Intravital imaging of vasculature in LG-6 15/0 collagen grafted animals. Bright ﬁeld image of vasculature entering tumor mass (I). Texas-red
dextral ﬁlled vasculature entering semi-solid tumor (dashed line indicates tumor boundary) (II). Texas-red dextral ﬁlled vasculature within tumor mass (III). Black cells are
melanophores within the tumor graft. Animals were imaged using a Nikon TE2000-U epiﬂuoresence microscope. (C) TMR loaded vasculature within 15/0-collagen tumors in
LG-6 tadpoles showing SHG signal (I), CFSE labeled tumor (II) and TMR loaded vessels (III) from 15/0-collagen tumor bearing animals. Animals were imaged using an
Olympus two-photon laser-scanning microscope. Images from representative animals shown.
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cells within the collagen matrix in living hosts (Fig. 3C). Previously
we have shown that though the modiﬁcation of immune mole-
cules present on tumor cells, we can enhance the inﬁltration of
leukocytes into the collagen tumor graft (Haynes-Gilmore et al.,
2014). Thus, it will be possible in future experiments to visualize in
real time interactions between tumor and immune cells in con-
junction with transgenic approach (Nedelkovska and Robert,
2012). Intriguingly, semi-solid 15/0 tumor grafts at later stages
(about 2 weeks post-grafting) also became inﬁltrated by high
numbers of melanophores. Such disorganization and abnormal
accumulation of melanophores is reminiscent of melanoma lesions
that often lead to skin cancer in human (Govindarajan et al., 2003;
Uong and Zon, 2010). Whether tumors at an advanced stage
produce factors or induce inﬂammatory signals triggering the
recruitment of these melanophores is currently unknown, but
merit further investigation. This abnormal accumulation may
correspond to the initial stage of malignant transformation that
leads to melanoma in humans. Xenopus melanophores share many
similarities with human melanocytes including their neural crest
origin during embryogenesis (Le Douarin and Dupin, 2012).
Importantly, neoplastic behavior of Xenopus melanophores can
be induced (Blackiston et al., 2011; Mondia et al., 2011; Tomlinson
et al., 2009). The ease to culture melanophores from 15/0 tumor
grafts may afford a convenient source for further experimentation;
in addition to the Xenopus melanophore cell lines that have been
described (Carrithers et al., 1999; Iuga et al., 2009). An attractive
feature of the present system is that the melanophore lines are
derived from MHC-deﬁned LG-6 or LG-15 isogenic clones and,
therefore, can be adoptively transferred into LG-6 or LG-15 tadpole
recipients for studying their neoplastic potential in vivo.
As a ﬁnal remark, it is noteworthy that the use of cold blooded
vertebrates such as Xenopus for studying tumor development
(particularly for intravital studies) has ethical advantages over
the use of mammalian models and is also preferred by animal care
committees.
In conclusion, we have developed a novel intra-vital semi-solid
tumor model in transparent tadpoles, which recapitulates many of
the functional characteristics of mammalian tumorigenesis. The
availability of a reliable comparative model that is cost-effective
and easily accessible to manipulation should reveal useful for the
development of new drugs targeting angiogenesis and extracel-
lular matrix or promoting antitumor immunity.
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